APA (7th ed.) Citation

Wang, Y., Wu, D., Zhang, X., Li, Y., He, Y., Liu, Q., . . . Zhang, Y. (2024). A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China. BMC medicine, 22(1), 142-11. https://doi.org/10.1186/s12916-024-03348-5

Chicago Style (17th ed.) Citation

Wang, Ying, et al. "A Phase II Study of Belumosudil for Chronic Graft-versus-host Disease in Patients Who Failed at Least One Line of Systemic Therapy in China." BMC Medicine 22, no. 1 (2024): 142-11. https://doi.org/10.1186/s12916-024-03348-5.

MLA (9th ed.) Citation

Wang, Ying, et al. "A Phase II Study of Belumosudil for Chronic Graft-versus-host Disease in Patients Who Failed at Least One Line of Systemic Therapy in China." BMC Medicine, vol. 22, no. 1, 2024, pp. 142-11, https://doi.org/10.1186/s12916-024-03348-5.